Article Details

AstraZeneca: Tezspire Gets EU Approval To Treat Severe Asthma - Finanznachrichten

Retrieved on: 2022-09-21 06:47:43

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca: Tezspire Gets EU Approval To Treat Severe Asthma - Finanznachrichten. View article details on hiswai:

Excerpt

LONDON (dpa-AFX) - British drug major AstraZeneca Plc (AZN.L, AZN) Wednesday said its Tezspire (tezepelumab) has been approved in the European ...

Article found on: www.finanznachrichten.de

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up